Spiroindalones

Details for Australian Patent Application No. 2008254270 (hide)

Owner Merck & Co., Inc.

Inventors Fletcher, Joan M.; Vachal, Petr; Hale, Jeffrey J.; Miao, Shouwu

Agent Spruson & Ferguson

Pub. Number AU-A-2008254270

PCT Pub. Number WO2008/144266

Priority 60/930,416 16.05.07 US

Filing date 12 May 2008

Wipo publication date 27 November 2008

International Classifications

A61K 31/44 (2006.01) - Non-condensed pyridines

C07D 401/00 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

12 November 2009 PCT application entered the National Phase

  PCT publication WO2008/144266 Priority application(s): WO2008/144266

21 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008254273-Methods for using vasopressin antagonists with anthracycline chemotherapy agents to reduce cardiotoxicity and/or improve survival

2008254261-The sorghum aluminum tolerance gene, SbMATE